Bupropion Tablet, Extended Release
Product Images NDC 65841-836

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion (NDC 65841-836). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

577eda07 Fd4e 494e A769 5338ba679892 02

Label for bupropion hydrochloride extended-release tablets USP (XL) 300 mg by Zydus Lifesciences Limited. The label states once-daily dosage, package size of 500 tablets, and includes warnings and storage instructions. It notes the product is Rx only and manufactured by Cadila Healthcare Ltd., Ahmedabad, India.*

FDA Label Image

577eda07 Fd4e 494e A769 5338ba679892 03

Label for bupropion hydrochloride extended-release tablets, USP (XL) 150 mg, once-daily oral tablets. The label shows the product name prominently with strength in orange, along with 500 tablets per container. The label includes NDC 65841-836-05 and warnings about bupropion use. The labeler is Zydus Lifesciences Limited, and manufacturing is by Cadila Healthcare Ltd., Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.